5-methanesulfonamido-1-indanones as an inhibitor of cyclooxygenase-2
USRE38103E1 · kind E1 · reissue
13Cited by
12References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 6, 2001 |
| Grant date | Apr 29, 2003 |
| Priority date | — |
| Expiry date | Apr 6, 2021 |
Classification
- Technology area (CPC —)General
Abstract
The Compound of Formula I and pharmaceutically acceptable sales thereof in the treatment of cyclooxygenase-2 mediated diseases are disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.